Approaches to Aging and Alzheimer's: What are We Learning from Clinical Trials?
Rachelle Doody, Professor of Neurology; Director, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine
Dr. Doody is the Effie Marie Cain Chair in Alzheimer’s Disease Research and Professor of Neurology at Baylor College of Medicine, where she directs the Alzheimer’s Disease and Memory Disorders Center (ADMDC). She received a B.A. from Rice University, a M.D. from Baylor College of Medicine, and completed internship and residency training at the Royal Victoria Hospital and Montreal Neurologic Institute in Montreal, and at Baylor College ofMedicine and has a Ph.D. in Cognitive Anthropology from Rice University where she studied the brain and language.
She has published over 170 original research articles, most dealing with the diagnosis, progression, or treatment of Alzheimer’s Disease. She has received multiple research grants, including a Zenith Award from the National Alzheimer’s Association, and designed and conducted numerous clinical trials of Alzheimer’s Disease therapies. She participates in National and International collaborative efforts, review boards, and advisory boards including Steering Committees for the NIH AD Cooperative Study and AD Neuroimaging Initiatives, and the Steering Committee for the Texas AD Research and Care Consortium.
Current research interests include studies to understand and model the progression of Alzheimer’s Disease, studies of clinical heterogeneity, and research and development of new medications to treat Alzheimer’s Disease. She works with many biopharmaceutical and large pharma collaborators in the assessment and experimental testing of a diverse group of potential AD therapies. She has served on the Texas Council on Alzheimer’s Disease and Related Disorders, and the Board of Directors for the Houston and Southeast Texas Chapter of the Alzheimer’s Association.